Gracillin T3774
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Gracillin can induce cell cycle arrest, oxidative stress, and apoptosis in HL60 cells, and has the potential to be developed as an antitumor agent. Gracillin can be selected as lead compounds for the development of new drugs against I. multifiliis.
CAS nr:
19083-00-2
Purity:
98%
Molecular Weight:
885,05
SMILES:
[C@@H]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O[C@H]1[C@@H]([C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@@]6([C@H]([C@@H]5[C@]4(CC[C@@H]3[C@]2(CC1)C)C)C)CC[C@H](CO6)C)CO)O
Formula:
C45H72O17
Pathway:
Cell Cycle/Checkpoint
Target:
cell cycle arrest
